Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2

Completed

Conditions studied: Tobacco Use Disorder

In brief

Lung cancer is the leading cause of cancer death in the United States. Currently it remains impossible to predict which smokers will get cancer. Each puff of a cigarette delivers a mixture of over 60 known carcinogens. Biomarkers that quantify carcinogen levels and metabolism are a useful tool and available to use. The purpose of this study is to assess the variability of tobacco smoke carcinogen biomarker levels over one year in a group of smokers.

Key facts

Study ID

NCT00158145

Run by

National Institute on Drug Abuse (NIDA)

People needed

72

Starts

2005-09-01

Expected to finish

2007-04-01

Last updated by the study team

2017-01-10

Who can join

Age: 55 and older, up to 74. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Currently smokes
• Intends to continue smoking for the 12 months following enrollment

You may not qualify if…

• Unstable physical or mental condition

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.